Thermo Fisher Scientific reported second-quarter 2026 revenue of $11.99 billion and EPS of $6.03. The company exceeded Wall Street expectations for both revenue and earnings. Thermo Fisher reaffirmed its full-year 2026 EPS guidance after the strong quarterly performance.
Key facts
An SEC Form 144 filing on August 6, 2026 indicates a proposed sale of 5,850 shares of common stock acquired through a stock option exercise with an aggregate market value of $3,393,000.00. source
The Form 144 transaction was handled by Fidelity Brokerage Services LLC. source